Evidence map›Paper›PMID 37119268›Full record

ArticleThe oncologist2023

Race/Ethnicity and Gender Representation in Hematology and Oncology Editorial Boards: What is the State of Diversity?

Shruti R Patel, Ivy Riano, Inas Abuali, Angela Ai, Gabriella Geiger, Jacqueline Pimienta, Adriana Ramirez Roggio, Natasha Dhawan, Nazli Dizman, Alexandra Lizette Salinas and 2 more

Abstract read
In one paragraph

Article in The oncologist, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. A Survey Study To Assess the Diversity and Inclusion in Nephrology Journal Editorial Leadership.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shruti R PatelDivision of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0002-4641-1003
Ivy RianoDivision of Hematology and Oncology, Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Inas AbualiDivision of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Angela AiDepartment of Medicine, Olive View-UCLA, Sylmar, CA, USA.ORCID 0000-0002-6064-4700
Gabriella GeigerDepartment of Internal Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.
Jacqueline PimientaDepartment of Internal Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA.
Adriana Ramirez RoggioDepartment of Internal Medicine, Universidad Central del Caribe, Bayamon, Puerto Rico.
Natasha DhawanDivision of Hematology and Oncology, Dartmouth Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
Nazli DizmanDepartment of Medicine, Yale School of Medicine, New Haven, CT, USA.
Alexandra Lizette SalinasDepartment of Internal Medicine, Universidad Autónoma de Guadalajara, Zapopan, Mexico.
Hugo Pomares-MillanDepartment of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden.
Narjust FlorezDepartment of Thoracic Oncology, Dana Farber Cancer Institute, Harvard School of Medicine, Boston, MA, USA.ORCID 0000-0002-7814-1773

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWomen and underrepresented groups in medicine hold few academic leadership positions in the field of hematology/oncology. In this study, we assessed gender and race/ethnicity representation in editorial board positions in hematology/oncology journals. MATERIALS AND

methodsEditorial leadership board members from 60 major journals in hematology and oncology were reviewed; 54 journals were included in the final analysis. Gender and race/ethnicity were determined based on publicly available data for Editor-in-Chief (EiC) and Second-in-Command (SiC) (including deputy, senior, or associate editors). Descriptive statistics and chi-squared were estimated. In the second phase of the study, editors were emailed a 4-item survey to self-identify their demographics.

resultsOut of 793 editorial board members, 72.6% were men and 27.4% were women. Editorial leadership were non-Hispanic white (71.1%) with Asian editorial board members representing the second largest majority at 22.5%. Women comprised only 15.9% of the EiC positions (90% White and 10% Asian). Women were about half as likely to be in the EiC position compared with men [pOR 0.47 (95% CI, 0.23-0.95, P = .03)]. Women represented 28.3% of SiC editorial positions. Surgical oncology had the lowest female representation at 2.3%.

conclusionWomen and minorities are significantly underrepresented in leadership roles on Editorial Boards in hematology/oncology journals. Importantly, the representation of minority women physicians in EiC positions is at an inexorable zero.

Indexed as

HematologyPhysicians, WomenEthnicityFemaleHumansMaleMedical Oncologyeditorial boardseditorsjournalsoncologyunderrepresented in medicinewomen

Identifiers

PMID37119268
PMCPMC10322130

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.